THROMBOPHILIA TOTAL PROFILE

Original price was: ₹23,200.00.Current price is: ₹23,000.00.

+919092026085

Description

Method: Chromogenic Assay, Electromechanical Clot Detection, Photo-optical Clot Detection, Immunoturbidimetry, EIA, Real Time PCR, CMIA
Comment: Samples received on holidays will be reported in next schedule/next working day.
Price: 23200.00
Report: Sample Mon / Thu by 9 am; Report Wed / Sat
Usage: Thrombophilia evaluations are usually performed to assess the need to extend anticoagulation, hence testing should be performed in a steady state, remote from the acute event. Laboratory assays to detect thrombophilic states include highly sensitive and specific test like molecular diagnosis, immunologic and functional assays. Many coagulation factors and inhibitors are affected during acute thrombosis, acute illnesses, inflammatory conditions, pregnancy & certain medications. Antithrombin is decreased by heparin and acute thrombosis whereas protein C & S levels are increased during acute thrombosis, but decreased by Warfarin. Antiphospholipid antibodies like lupus anticoagulants, anti cardiolipin antibodies & anti beta 2 glycoprotein antibodies are also associated with thromboembolic disease states. Higher levels of factor VIII (>150%), factor V leiden mutations and increased homocysteine levels are also associated with increased risk of thromboembolic disease.
Doctor Specialty: Hematologist
Disease: Disorders of Coagulation
Components: *Protein C, Functional *Protein S Antigen, Free *Antithrombin Activity Functional *Mixing studies APTT *Lupus anticoagulant panel *Homocysteine quantitative, serum *Cardiolipin antibody IgG & IgM *Beta-2 Glycoprotein 1 IgG & IgM *Factor V Leiden mutation analysis *Factor VIII Functional/Activity
Courier Charges:
Home Collection: Available
Department: COAGULATION
Pre Test Information: Overnight fasting is preferred.  It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent from the treating Physician.